FDA Investigator Elodie X Tong Lin
Elodie X Tong Lin has conducted inspections on 98 sites in 4 countries as of 23 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
98
Last Inspection Date:
23 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Germany,
Korea (Republic of),
Sudan
FDA Investigators that have inspected at least one site in common with Elodie X Tong Lin:
Alex G Kalugin,
Alexis R Ajello,
Alice A Blair,
Alla Dubrovsky,
Amanda N Schaupp,
Amogh Pathi,
Andrew B Slarve,
Andrew E Kay,
Andrew T Todd,
Angel K Sandhu,
Angela D Wise,
Anna L Viveros Hernandez,
Annie H Lam,
Ashar P Parikh,
Belinda E Clifton,
Benny Y Gong,
Brian R Henderson,
Bruce D Broidy,
Capri R Woolridge,
Carrie E Thrasher,
Cathleen A Carr Sharpe,
Celeste K Wong,
Chloe Anne Leong,
Christine M Parmentier,
Cindy W Lewis,
Courtney R Bolton,
Craig K Hopkins,
Cynthia L Ford,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Daniel Velasquez,
Darla R Bracy,
David G Eng,
David J Leray,
David P Moorhead,
Davis,
Deborah K Richardson,
Debra C Yamane,
Debra D Devlieger,
Debra J Fracassa,
Dena L Jacobs,
Denise Connelly,
Durell L Giles,
Edna J Hidalgo,
Eileen T Dupont,
Elisabeth A Drevet,
Emal Wahab,
Emmanuel O Kerry,
Eric C Nielsen,
Eric J Heinze,
Eric W Anderson,
Erica Fernandez,
Erica R Pomeroy,
Estefania Fernandez,
Francisco,
Frank P Bianco,
Frans E Mercado,
Gillenwater,
Greg K Keshishyan,
Gulshan R Anand,
Helen J Hamaoka,
Holly A Rhodes,
Indigo A Doll,
Ingrid A Zambrana,
Ismael Garibay,
Jacqueline O Snell,
James C Lee, PharmD,
James C Yee,
Jane C Chen,
Janice R Small,
Janice Wai,
Jazmine M Welcher,
Jeanne A Young,
Jeffrey W Shrifter, DPM,
Jennifer Crumb,
Jennifer L Johnson,
Jennifer S King,
Jenny K Yee,
Jessica B Clark,
Jessica B Darneille,
Joan T Briones,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Liu,
John R Myung,
Jolene S Hedgecock,
Jonathon A Yenovkian,
Joseph C Yen,
Joseph M Willems,
Joseph Tibay,
Juan A Morales,
Judy C Nepsa,
Justin M Runac,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karla J Gibler,
Katie T Duong,
Kavita K Lalwani,
Kawshalya Pathiraja,
Kevin Lee,
Kevin P Foley,
Kevin T Gerrity,
Khanh T Van,
Kimberly L Anderson,
Kin T Moy,
Kristin M Abaonza,
Krystina M Jackson,
Lance A Finnical,
Larkin R Buckalew,
Lawton W Lum,
Lea Lakes,
Lija V Fellows,
Lilly O Barton,
Linda Linh N Adams,
Linda S Shook,
Lisa H Nakagawa,
Lorraine N Dixon,
Lorraine N Williams,
Lourdes Andujar,
LT Mark A Chen, MPH,
Lydia S Chan,
Lynn L Wong,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Margo C Jones,
Maridali Deleon Torres,
Marissa J Chan,
Mark E Baldwin,
Mark I Nakano,
Mark L Collins,
Mary C Acton,
Mary C Wall,
Mary R Hole,
Matthew A Walburger,
Mcgrewp,
Melody M Ragasa Leong,
Melvin Dorin,
Michael D Kawalek,
Michelle L Tripp,
Monique C Lo,
Naveen B Walker,
Ngoc B Kelsch,
Nicole Yuen,
Noelani K Chiu,
Nympha V Florendo,
Patricia F Alberico,
Patrick E Gainer,
Peter E Baker,
Phung,
Quynh H Strandberg,
Rachel J Cantrell,
Randall F Albright,
Randall J Plunkett,
Randall P Zielinski,
Rashonda N Rucker,
Raymond Souweha,
Robert P Neligan,
Roberta K Smith,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sabino S Camacho,
Samuel J Barone, III,
Sandra S Saniga,
Sara M Richardson,
Savannah E Samp,
Scott J Matsuda,
Sean P Desbrow,
Selene T Torres,
Sharon L Shane,
Siobhan A Gallagher,
Sparky L Bartee,
Steve P Yost,
Steven B Chiu,
Steven M Galvez,
Stuart Kim,
Stuart W Russell,
Sundy V Sedwick,
Teresa I Navas,
Terrence Gee,
Thomas N Adjabeng,
Timothy C Grome,
Tomanik'e C Banks,
Travelle D Mason,
Trusten J Robles,
Vebina K Sethi,
Vi T Au,
Victoria L Morgan,
Wayne L Jefferson,
Wen Jun Peng,
Wendy S Shenk,
William J Foust,
William J Weis,
Yen Tso Kuo
Elodie X Tong Lin's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2017 | FDA 483 | Harbinger Group, LLC. dba Misionero - Form 483, 2017-05-12 |
August, 2017 | EIR | Mann Packing LLC. - EIR, 2017-08-09 |
March, 2017 | FDA 483 | Hanbit Enterprises Inc. dba Jack and the Bean Stalk - Form 483, 2017-03-07 |
April, 2017 | FDA 483 | Christopher Ranch LLC - Form 483, 2017-04-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more